Good Clinical Practices (GCP) Services
Global Experts in Clinical Trials for Real-World Medical Breakthroughs.
We specialize in conducting clinical trials globally to evaluate the effectiveness of Zenovel medical interventions in real-life clinical settings through our Good Clinical Practice (GCP) Services
We provide comprehensive GCP services to ensure that clinical trials meet the highest Good Clinical Practice standards—covering planning, execution, monitoring, and reporting at every stage of clinical studies.
With over 20 years of global experience as a trusted GxP service provider, Zenovel offers end-to-end Good Clinical Practice (GCP) services to the pharmaceutical industry, supporting compliance with regulations issued by agencies such as the FDA and EMA, protecting patient safety, and enabling the development of safe and effective medicines for global markets. As an emerging leader in clinical research solutions, we deliver a one-stop approach that combines expertise, reliability, and innovation.
1. Audit
Have partner with Zenovel to ensure the highest standards of integrity, quality, and compliance in your clinical studies for GCP audit requirements
Our team of knowledgeable auditors offers GCP audit services to ensure clinical trials meet the highest ethical, regulatory and scientific standards, ensuring compliance with international guidelines as well as local regulatory requirements, protecting the integrity and credibility of the research.
2. Risk Based Monitoring
We ensure your clinical trial excellence through our proactive risk management.
We offers advanced Risk-Based Monitoring (RBM) services for clinical studies (BA/BE, Clinical trials, PK studies), focusing on detecting, evaluating, and minimizing risks to ensure patient safety, data integrity, and regulatory compliance, while reducing operational costs.
3. Pre-Inspection Readiness
We ensure cliinical trial sites are inspection ready with pre-inspection readiness services.
We, at Zenovel provide comprehensive pre-inspection readiness services for clinical studies/CRO/Sites, ensuring compliance with GCP standards. Our team conducts mock inspections, reviews study documentation, provides staff training, and optimizes facility preparation.
We offer customized compliance checklists and post-inspection support to mitigate risks and maintain on-going compliance.
4. Project Management
We offer customized project management services for clinical studies, ensuring regulatory and GCP compliance and positive results.
We offer project management services for clinical studies, ensuring efficient execution and regulatory and GCP compliance. Our experienced team manages trial planning, vendor management, risk mitigation, and data integrity, ensuring successful outcomes and patient safety throughout the project lifecycle.
5. Sponsor oversight
We believe in fostering performance with extensive sponsor oversight for assuring successful trial acquisition.
We provide sponsor oversight services for clinical trials, ensuring efficient execution and regulatory and GCP compliance. Our team collaborates with sponsors and take all delegated responsibility on behalf of sponsor to plan trials, manage vendors, and maintain data integrity, and also prioritize risk management, site oversight, and data integrity, ensuring successful trial outcomes.
6. QMS Setup
We emphasize the importance of integrating quality in every step through competent QMS configuration for GCP compliance.
Zenovel focuses on establishing strong Quality Management System (QMS) as per the GCP and Regulatory standard. We offer services like SOP and policy development, document management, training, quality control tasks, and many others ensuring high-quality and compliant trial conduct through a continuous development process.
7. PK Stat Review
We give a complete guide on professional PK statistical analysis, emphasizing the importance of understanding it for informed decision-making.
We provide expert pharmacokinetic statistics evaluation services, ensuring in-depth data interpretation and analysis in clinical studies. Our statisticians evaluate concentration-time profiles, PK parameters, and apply relevant statistical procedures to extract useful information about drug exposure and pharmacokinetics, along with provide simple statistical reports for regulatory filings and decision-making.
8. CRO Setup / Upgradation
We enhance your CRO operations with skilled GCP Compliance setup and upgrades.
We offer comprehensive CRO setup and upgradation services as per the GCP and Regulatory standard, including system development, vendor management, process optimization, QMS implementation, and facility development as per the regulatory and GCP compliance. Our customized strategy for CRO setup/upgradation, ensuring effective clinical trial management, improving output, calibre, and compliance with regulations. Partner with Zenovel for professional assistance in building and refining your CRO.
9. CSV
We offer an expert CSV for GCP-compliant Clinical Studies, ensuring data integrity.
We provide expert pharmacokinetic statistics evaluation services, ensuring in-depth data interpretation and analysis in clinical studies. Our statisticians evaluate concentration-time profiles, PK parameters, and apply relevant statistical procedures to extract useful information about drug exposure and pharmacokinetics, along with provide simple statistical reports for regulatory filings and decision-making.
10. Training
We focus on the importance of expert training on various GCP operations in enhancing the excellence of clinical research.
Zenovel offers comprehensive training ensuring adherence to GCP, regulatory guidelines and protocol compliance. It enhances trial quality, mitigates risks, and ensures regulatory compliance.
11. Contract Staffing
We offer flexible GCP staffing solution for seamless clinical trial.
Zenovel provides contractual recruiting for global CROs and pharmaceutical firms, offering Full-Time Equivalent (FTE) models with experienced CRAs and Auditors from over 30 countries, ensuring high standards of quality and compliance. Our experienced staffs include CRA, CTA, CRC, Project Manager, Data Manager, Medical & Scientific Writer, allowing for efficient management of trial workload and timelines.
People Also Ask (FAQs)
Good Clinical Practice (GCP) is an international ethical and scientific quality standard for designing, conducting, recording, and reporting clinical trials involving human participants. GCP ensures the safety, rights, and well-being of trial participants while guaranteeing that clinical data is reliable and credible. Pharmaceutical and biotech companies must follow GCP guidelines to obtain regulatory approval from global authorities such as the FDA, EMA, and other regulatory agencies.
GCP audits evaluate whether clinical trials follow regulatory guidelines and ethical standards. These audits help pharmaceutical companies identify compliance gaps, improve study documentation, and prepare for inspections by regulatory authorities such as the FDA, EMA, and other global agencies.
Risk-Based Monitoring (RBM) is a modern clinical trial monitoring strategy that focuses on identifying and managing the most critical risks affecting patient safety and data quality. RBM combines centralized data monitoring with targeted site visits to improve efficiency while maintaining regulatory compliance
GCP consulting helps pharmaceutical, biotech, and CRO organizations design and conduct clinical trials that comply with international guidelines such as ICH-GCP. Consultants support areas like clinical trial planning, monitoring, regulatory compliance, documentation management, and inspection readiness.
Zenovel provides comprehensive GCP services including GCP audits, risk-based monitoring, pre-inspection readiness, project management, sponsor oversight, QMS setup, PK statistical review, CRO setup and upgradation, computer system validation (CSV), training, and contract staffing for clinical trial
Blogs and news
Our Latest Article
India is a significant player in the global pharmaceuticals sector, characterized by a diverse population and cost-effective infrastructure. However, its potential in clinical research is hindered by complex regulatory challenges that delay innovations and deter investment, affecting the timely market introduction of life-saving drugs. This blog discusses the major obstacles
The FDA issued 466 Form 483s to drug organizations in FY 2022, more than double the previous year, highlighting significant quality failures in the pharmaceutical sector. For startups and scale-ups seeking market approval, the excitement of innovation often conflicts with the strict requirements of current good manufacturing practices (cGMP). Although
Introduction Liposomal Amphotericin-B is a critical antifungal medication that requires careful attention during Bioequivalence (BE) studies. These studies aim to demonstrate the similarity of a generic liposomal Amphotericin B formulation to the reference drug in terms of pharmacokinetics. Zenovel, with its extensive experience in monitoring Amphotericin B studies, can play
In the pharmaceutical and biotechnology industries, obtaining regulatory approval is essential prior to introducing new drugs or biologics to the market. A pivotal aspect of this approval process is the FDA Pre-Approval Inspection (PAI), which involves a comprehensive assessment of manufacturing facilities, processes, and data integrity to ensure adherence to
Risk Based Monitoring (RBM) is a more efficient alternative to traditional clinical trials, focusing on high-risk areas through data-driven insights. It ensures patient safety, data integrity, and regulatory compliance while reducing costs and timelines. However, the success of RBM depends on the competency of monitors, who identify risks, analyze data,
Welcome to the Zenovel Blog! We are a leading provider of drug regulatory consulting and education, focusing on advancing pharmaceutical innovation while ensuring safety and compliance. This blog delves into the essentials of Drug Regulatory Affairs (DRA), covering its scope, career opportunities, and intricate processes involved in bringing new drugs
